AndreiHoriaIagaruMD

Nuclear Medicine • Stanford, CA

Professor, Radiology, Stanford University Medical Center

Join to view full profile

Dr. Iagaru is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Iagaru's full profile

Already have an account?

Office
300 Pasteur Dr
Room H-2200
Stanford, CA 94305
Phone+1 650-725-4711

Fax+1 650-498-5047
Is this information wrong?

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Nuclear Medicine, 2004 - 2006
Graduate HospitalInternship, Internal Medicine, 2003 - 2004
Carol Davila University of Medicine and PharmacyClass of 2000

Certifications & Licensure

CA State Medical License 2005 - 2025
PA State Medical License 2003 - 2004
American Board of Nuclear Medicine Nuclear Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Clinical Trials

Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA Start of enrollment: 2007 May 01
Withdrawn
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases Start of enrollment: 2006 Jan 01
Completed
Phase 2
Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy Start of enrollment: 2007 Aug 01
Completed
68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors
No longer available
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas Start of enrollment: 2014 Dec 01
Terminated
Not Applicable
68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment Start of enrollment: 2017 May 20
Completed
Phase 2, Phase 3
68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery Start of enrollment: 2016 Apr 18
Completed
Phase 2, Phase 3
Standard PET/CT vs. Digital PET/CT Start of enrollment: 2017 Mar 29
Completed
Not Applicable
18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation Start of enrollment: 2017 Aug 02
Terminated
Phase 2
Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors Start of enrollment: 2017 Feb 15
Completed
Not Applicable
68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer Start of enrollment: 2017 Apr 10
Completed
Phase 2
PET/MRI Evaluation of Cardiac Amyloid Start of enrollment: 2016 May 26
Completed
Early Phase 1
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals Start of enrollment: 2014 May 27
Completed
Phase 2
F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer
No longer available
Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer Start of enrollment: 2020 Dec 15
Completed
Phase 2
68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer Start of enrollment: 2019 Jan 14
Completed
Phase 2
68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy Start of enrollment: 2019 Apr 09
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

The Age of Theragnostics.
Andrei Iagaru, Heather Jacene> ;PET Clinics. 2024 Apr 8
Guiding principles on the education and practice of theranostics.
Thomas N B Pascual, Diana Paez, Andrei Iagaru, Gopi Gnanasegaran, Sze Ting Lee, Mike Sathekge, John M Buatti, Francesco Giammarile, Akram Al-Ibraheem, Manuela Arevalo ...> ;European Journal of Nuclear Medicine and Molecular Imaging. 2024 Mar 8
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET.
Kip E Guja, Kristen N Ganjoo, Andrei Iagaru> ;Seminars in Nuclear Medicine. 2024 Mar 2
Ga-RM2 PET-MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trial.
Heying Duan, Farshad Moradi, Guido A Davidzon, Tie Liang, Hong Song, Andreas M Loening, Shreyas Vasanawala, Sandy Srinivas, James D Brooks, Steven Hancock, Andrei Iagaru> ;The Lancet. Oncology. 2024 Apr 1
1 citations
Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review.
Tasnim Khessib, Priyanka Jha, Guido A Davidzon, Andrei Iagaru, Jagruti Shah> ;Seminars in Nuclear Medicine. 2024 Mar 1
Imaging GRPr Expression in Metastatic Castration-Resistant Prostate Cancer with [Ga]Ga-RM2-A Head-to-Head Pilot Comparison with [Ga]Ga-PSMA-11.
Fernández, R., Soza-Ried, C., Stephens, A., Müller, A., Schieferstein, H., Sandoval, C., Amaral, H., Kramer, V., Iagaru, A.> ;Cancers. 2023 Dec 29
2 citations
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer.
Daniela-Elena Oprea-Lager, Steven MacLennan, Anders Bjartell, Alberto Briganti, Irene A Burger, Igle de Jong, Maria De Santis, Uta Eberlein, Louise Emmett, Karim Fizaz...> ;European Urology. 2024 Jan 1
4 citations
International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology.
Patrick Veit-Haibach, Håkan Ahlström, Ronald Boellaard, Roberto C Delgado Bolton, Swen Hesse, Thomas Hope, Martin W Huellner, Andrei Iagaru, Geoffrey B Johnson, Andrea...> ;European Journal of Nuclear Medicine and Molecular Imaging. 2023 Oct 1
3 citations
Modified PROMISE criteria for standardized interpretation of gastrin-releasing peptide receptor (GRPR)-targeted PET.
Heying Duan, Guido A Davidzon, Farshad Moradi, Tie Liang, Hong Song, Andrei Iagaru> ;European Journal of Nuclear Medicine and Molecular Imaging. 2023 Nov 1
1 citations
PSMA PET for Detection of Recurrence.
Heying Duan, Andrei Iagaru> ;Seminars in Nuclear Medicine. 2024 Jan 1
2022 SNMMI Highlights Lecture: General Nuclear Medicine.
Andrei Iagaru> ;Journal of Nuclear Medicine. 2023 May 1
3 citations
SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the postLu-DOTATATE andLu-PSMA617 setting.
Hong Song, Valentina Ferri, Heying Duan, Carina Mari Aparici, Guido Davidzon, Benjamin L Franc, Farshad Moradi, Judy Nguyen, Jagruti Shah, Andrei Iagaru> ;European Journal of Nuclear Medicine and Molecular Imaging. 2023 Jul 1
1 citations
Neuroendocrine Tumor Diagnosis: PET/MR Imaging.
Heying Duan, Andrei Iagaru> ;PET Clinics. 2023 Apr 1
4 citations
Image-mode performance characterisation of a positron emission tomography subsystem designed for Biology-guided radiotherapy (BgRT).
Zhiqiang Hu, Matthew Bieniosek, Valentina Ferri, Andrei Iagaru, Nataliya Kovalchuk, Bin Han, Lei Xing, Lucas Vitzthum, Peter Olcott, Manoj Narayanan, Thomas Laurence, ...> ;The British Journal of Radiology. 2023 Jan 1
7 citations
A Pilot Study ofGa-PSMA11 andGa-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer.
Heying Duan, Pejman Ghanouni, Bruce Daniel, Jarrett Rosenberg, Alan Thong, Christian Kunder, Carina Mari Aparici, Guido A Davidzon, Farshad Moradi, Geoffrey A Sonn, An...> ;Journal of Nuclear Medicine. 2023 May 1
5 citations
A Pilot Study ofGa-PSMA11 andGa-RM2 PET/MRI for Evaluation of Prostate Cancer Response to High-Intensity Focused Ultrasound Therapy.
Heying Duan, Pejman Ghanouni, Bruce Daniel, Jarrett Rosenberg, Guido A Davidzon, Carina Mari Aparici, Christian Kunder, Geoffrey A Sonn, Andrei Iagaru> ;Journal of Nuclear Medicine. 2023 Apr 1
2 citations
89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma.
Yu-Jin Lee, Nynke S van den Berg, Heying Duan, E Carmen Azevedo, Valentina Ferri, Marisa Hom, Roan C Raymundo, Alex Valencia, Jessa Castillo, Bin Shen, Quan Zhou, Laur...> ;Clinical Cancer Research. 2022 Oct 14
3 citations
PET Imaging Using Gallium-68 (Ga) RM2.
Heying Duan, Andrei Iagaru> ;PET Clinics. 2022 Oct 1
3 citations
The use of advanced imaging in guiding the further investigation and treatment of primary prostate cancer.
Heying Duan, Andrei Iagaru> ;Cancer Imaging. 2022 Sep 3
3 citations
PSMA theragnostics for metastatic castration resistant prostate cancer.
Hong Song, Kip E Guja, Andrei Iagaru> ;Translational Oncology. 2022 Aug 1
2 citations
Evaluation of Liver and Renal Toxicity in Peptide Receptor Radionuclide Therapy for Somatostatin Receptor Expressing Tumors: A 2-Year Follow-Up.
Heying Duan, Valentina Ferri, George Albert Fisher, Shagufta Shaheen, Guido Alejandro Davidzon, Andrei Iagaru, Carina Mari Aparici> ;The Oncologist. 2022 Jun 8
14 citations
Correlation ofGa-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer.
Heying Duan, Lucia Baratto, Richard E Fan, Simon John Christoph Soerensen, Tie Liang, Benjamin Inbeh Chung, Alan Eih Chih Thong, Harcharan Gill, Christian Kunder, Tany...> ;Journal of Nuclear Medicine. 2022 Dec 1
5 citations
Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment.
Farshad Moradi, Heying Duan, Hong Song, Guido A Davidzon, Benjamin I Chung, Alan E C Thong, Andreas M Loening, Pejman Ghanouni, Geoffrey Sonn, Andrei Iagaru> ;Journal of Nuclear Medicine. 2022 Dec 1
Correction to: Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas.
R Laudicella, N Quartuccio, G Argiroffi, P Alongi, L Baratto, E Califaretti, V Frantellizzi, G De Vincentis, A Del Sole, L Evangelista, S Baldari, S Bisdas, Francesco ...> ;European Journal of Nuclear Medicine and Molecular Imaging. 2022 May 1
19 citations
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature.
Pierpaolo Alongi, Riccardo Laudicella, Helena Lanzafame, Andrea Farolfi, Paola Mapelli, Maria Picchio, Irene A Burger, Andrei Iagaru, Fabio Minutoli, Laura Evangelista> ;Cancers. 2022 Mar 31
Join now to see all

Journal Articles

Visualization of Diagnostic and Therapeutic Targets in Glioma with Molecular Imaging
Chirag B Patel, Guofan Xu, Andrei Iagaru, Frontiers in Immunology
18F-FPPRGD2 PET/CT in Patients with Metastatic Renal Cell Cancer
Alice C Fan, Andrei Iagaru, European Journal of Nuclear Medicine and Molecular Imaging

Press Mentions

US Is Facing a ‘Historical’ Shortage of Life-Saving Cancer DrugsApril 11th, 2023
Imaging Technique Predicts Risk of Prostate Cancer Recurrence After TreatmentJanuary 11th, 2023
Imaging Tests Predict the Risk of Prostate Cancer Coming Back After TreatmentJanuary 11th, 2023
Join now to see all